Deep Vein Thrombosis in Elderly Patients Hospitalized in Subacute Care Facilities: A Multicenter Cross-sectional Study of Risk Factors, Prophylaxis, and Prevalence

Archives of Internal Medicine

Volumn 163, Issue 21, 2003, Pages 2613-2618

  Bosson, Jean Luc ^a,c   Labarere, Jose ^b   Sevestre, Marie Antoinette ^c   Belmin, Joel ^c   Beyssier, Laurence ^c   Elias, Antoine ^c   Franco, Alain ^c   Le Roux, Philippe ^c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b LABORATOIRE TIMC IMAG   (France)

^c CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; AGING; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HOSPITALIZATION; HUMAN; IMMOBILIZATION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREMEDICATION; PREVALENCE; RISK FACTORS; SKILLED NURSING FACILITIES; SUBACUTE CARE; VENOUS THROMBOSIS;

EID: 0344420379     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.21.2613     Document Type: Article

References (23)

1. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
2. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
3. Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism: International Consensus Statement: guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001;20:1-37.
4. Samama MM, Cohen AT, Darmon JY, et al, for the Prophylaxis in Medical Patients With Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999;341:793-800.
5. Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost. 2000;83:14-19.
6. Murtaugh CM, Litke A. Transitions through postacute and long-term care settings: patterns of use and outcomes for a national cohort of elders. Med Care. 2002;40:227-236.
7. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809-815.
8. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med, 1991;115:591-595.
9. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415-3420.
10. Barrellier MT, Bosson JL, Vignon C, et al. Echo-doppler for early diagnosis of deep venous thrombosis in orthopedic surgery and traumatology: a retrospective study of 1,647 patients. J Mal Vasc. 1994;19:298-307.
11. Bosson JL, Riachi M, Pichot O, Michoud E, Carpentier PH, Franco A. Diameters of acute proximal and distal deep venous thrombosis of the lower limbs. Int Angiol. 1998;17:260-267.
12. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58:690-700.
13. Localio R, Berlin J, Ten Have T, Kimmel S. Adjustments for center in multicenter studies: an overview. Ann Intern Med. 2001;135:112-123.
14. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992;305:567-574.
15. Prandoni P, Bruchi O, Sabbion P, et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med. 2002;162:1966-1971.
16. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358:9-15.
17. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980.
18. White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343:1758-1764.
19. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med. 2002;162:1465-1471.
20. Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: a meta-analysis. Ann Intern Med. 1995;122:47-53.
21. Bressollette L, Nonent M, Oger E, et al. Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients - the TADEUS project. Thromb Haemost. 2001;86:529-533.
22. Davidson BL. What are the most reliable detection methods for deep vein thrombosis and pulmonary embolism to be used as endpoints in trials of venous thromboprophylaxis? Haemostasis. 1998;28(suppl 3):113-119.
23. Lederle FA. Heparin prophylaxis for medical patients? Ann Intern Med. 1998;128:768-770.